Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays

This publication has 30 references indexed in Scilit:

• Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma
  Lung Cancer, 2002
• Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas
  British Journal of Cancer, 2002
• Status of c‐erbB‐2 in gastric adenocarcinoma: A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme‐linked immuno‐sorbent assay
  International Journal of Cancer, 2002
• Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma
  Cancer, 2001
• Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
  Journal of Clinical Oncology, 1999
• Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research
  Breast Cancer Research and Treatment, 1995
• ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.
  Proceedings of the National Academy of Sciences, 1992
• Association of C‐erbB‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancer
  International Journal of Cancer, 1991
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12–21.32
  Genomics, 1989